A BEMER mat is a full-body pad that sends low-intensity pulsed electromagnetic fields (PEMF) into your body, designed to stimulate blood flow in small blood vessels. The mat is the central component of the BEMER system, a German-engineered device that has FDA clearance as a Class II medical device. It’s one of the more expensive wellness devices on the market, with the base system priced at $5,490.
How the BEMER Mat Works
BEMER stands for Bio-Electro-Magnetic-Energy-Regulation. The mat, called the B.Body applicator, generates a pulsed electromagnetic signal at a very low intensity, between 7 and 35 microtesla. For context, that’s far weaker than a standard MRI machine and even weaker than the Earth’s own magnetic field, which sits around 25 to 65 microtesla depending on location.
What makes the BEMER signal distinct from other PEMF devices is its patented waveform. Rather than a simple repeating pulse, the signal uses half-sinusoidal intensity modulations at two frequency ranges: 8 to 11 Hz and 28 to 31 Hz. The company describes this as a “bio-rhythmically defined signal,” meaning the pulse pattern is designed to match natural rhythms in the body’s smallest blood vessels. This specific configuration is protected by multiple international patents and isn’t used in any competing device.
What It Targets: Microcirculation
The core claim behind BEMER therapy centers on microcirculation, the flow of blood through your tiniest blood vessels, including capillaries and the small arterioles and venules that feed them. These vessels are responsible for delivering oxygen and nutrients to your tissues and carrying away waste products. About 75% of your circulatory system consists of these micro-vessels.
The BEMER signal aims to stimulate something called vasomotion, the rhythmic contraction and relaxation of small blood vessel walls. Research on the device has reported that this stimulation leads to an increase in the diameter of small blood vessels, a greater number of open capillaries, and improved blood flow volume in both arteries and veins. When vasomotion increases, drainage from the capillary network into the venules also improves, which helps clear metabolic waste more efficiently.
A preliminary study on patients with jaw-related pain found that the BEMER group experienced measurable improvements in pain scores and physical function over a two-month period. The B.Spot applicator, a smaller targeted pad sold separately, delivers a stronger signal (60 to 100 microtesla) for localized use on specific muscle groups or joints.
What a Typical Session Looks Like
The recommended protocol is simple: two 8-minute sessions per day. You lie on the mat, select an intensity level through the control unit, and the device runs through its programmed signal cycle. Most people use it once in the morning and once in the evening. The mat is roughly the size of a yoga mat, so it fits on a bed, couch, or floor.
The experience itself is subtle. Because the magnetic field is so weak, most users don’t feel a strong sensation during the session. This is different from some higher-intensity PEMF devices that produce a noticeable pulsing or tingling. BEMER’s approach relies on the specific signal pattern rather than raw power.
FDA Status and What It Means
The BEMER Therapy System Evo received FDA 510(k) clearance (number K231368), which classifies it as a Class II medical device. This is an important distinction: 510(k) clearance means the FDA determined the device is substantially equivalent to other legally marketed devices and is reasonably safe to use. It does not mean the FDA has verified the manufacturer’s specific health claims. The cleared indication is focused on improving local blood flow in healthy muscles to support muscle performance.
Who Should Avoid It
BEMER therapy has several clear contraindications. People who have received organ transplants, tissue transplants from donors, or allogeneic stem cell or bone marrow transplants should not use the device while taking immunosuppressive medications. The concern is that boosting microcirculation could interfere with the immune suppression needed to prevent transplant rejection.
If you have an electronic implant like a pacemaker, defibrillator, brain stimulator, or insulin pump, use is only considered safe if the implant manufacturer has confirmed that the BEMER’s electromagnetic field won’t exceed the implant’s interference threshold. Because this can’t be guaranteed with absolute certainty, caution is warranted.
Cost and What You Get
The BEMER Classic-Set Evo, which includes the B.Body mat and the control unit, retails for $5,490. The Pro set, which adds the smaller B.Spot applicator and other accessories, costs more. This price point puts BEMER significantly above most consumer PEMF mats, which typically range from $500 to $2,000. The company attributes the premium to its patented signal technology and nearly two decades of research and development.
BEMER also operates through a network of independent distributors, which means you may encounter the product through someone selling it directly rather than through a traditional retail channel. This multi-level distribution model is worth being aware of, as the person recommending the device may also be earning a commission on the sale.
How BEMER Compares to Standard PEMF Mats
The broader PEMF category includes dozens of devices at various price points, and they all share the basic principle of delivering electromagnetic pulses to the body. Where they differ is in signal characteristics: frequency, intensity, waveform shape, and timing patterns. Most generic PEMF mats use simple square or sawtooth waveforms at higher intensities.
BEMER’s distinguishing feature is its specific low-intensity, complex waveform designed to target vasomotion in micro-vessels. Whether this patented signal delivers meaningfully better results than a simpler, less expensive PEMF device is the central question for anyone considering the purchase. The existing research on BEMER specifically, while showing some positive results in areas like pain and microcirculation, consists mostly of small or preliminary studies rather than large-scale clinical trials. The device has genuine physiological plausibility and regulatory clearance, but the evidence base is still modest relative to the price tag.